According to stock exchange release on May 30th, Aspo's subsidiary Leipurin has agreed to purchase the entire share capital of the Swedish Kobia Ab from the Swedish Abdon Group. This business arrangement has now received the approval of the competition authority in Sweden and the transaction has entered into force on September 1, 2022.